BTIG Maintains Buy on Abbott Laboratories, Lowers Price Target to $131

Abbott Laboratories -0.84%

Abbott Laboratories

ABT

96.00

-0.84%

BTIG analyst Marie Thibault maintains Abbott Laboratories (NYSE: ABT) with a Buy and lowers the price target from $140 to $131.